Adamis Pharmaceuticals (NASDAQ:ADMP) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP – Free Report) in a report issued on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Adamis Pharmaceuticals Price Performance Adamis Pharmaceuticals has a 1 year low of $0.75 and a 1 year high of $26.18. The firm’s 50 day […]

Related Keywords

,Securities Exchange Commission ,News Ratings For Adamis Pharmaceuticals Daily ,Adamis Pharmaceuticals Co ,Adamis Pharmaceuticals Company Profile ,Adamis Pharmaceuticals Price Performance ,Armistice Capital ,Nasdaq ,Adamis Pharmaceuticals ,Adamis Pharmaceuticals Corporation ,Institutional Trading Of Adamis Pharmaceuticals ,Free Report ,Get Free Report ,Pharmaceuticals Corporation ,Adamis Pharmaceuticals Daily ,Nasdaq Admp ,Admp ,Medical ,Initiated Coverage ,Stocknews Com ,